Loading...
Please wait

Flu season’s here, and older adults fifty and up just got a game-changing shield: the first mRNA flu vaccine approved by the FDA. Unlike traditional shots that use weakened viruses, this new tech delivers genetic instructions to your cells, teaching them to fight flu before it strikes. Faster to produce and more precise than egg-based vaccines, it’s designed to outsmart mutating strains — especially critical for seniors, who face higher risks of pneumonia, organ failure, and death. Early trials show strong results in this age group, prompting the FDA to limit rollout to those 50+. Doctors say it’s worth discussing with your provider — because staying ahead of the flu is now smarter, faster, and more powerful than ever.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/09946b814fb632db